Labcorp Return on Investment 2010-2024 | LH
Current and historical return on investment (ROI) values for Labcorp (LH) over the last 10 years.
| Labcorp ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-09-30 |
$0.75B |
$13.60B |
6.25% |
| 2024-06-30 |
$0.75B |
$11.13B |
6.39% |
| 2024-03-31 |
$0.72B |
$11.08B |
5.80% |
| 2023-12-31 |
$0.73B |
$12.01B |
5.39% |
| 2023-09-30 |
$0.79B |
$12.38B |
5.57% |
| 2023-06-30 |
$0.92B |
$13.91B |
6.09% |
| 2023-03-31 |
$1.08B |
$15.48B |
6.96% |
| 2022-12-31 |
$1.44B |
$15.22B |
9.16% |
| 2022-09-30 |
$2.01B |
$15.51B |
12.70% |
| 2022-06-30 |
$2.40B |
$15.84B |
15.06% |
| 2022-03-31 |
$2.68B |
$16.19B |
16.81% |
| 2021-12-31 |
$3.05B |
$15.78B |
19.49% |
| 2021-09-30 |
$3.82B |
$16.03B |
24.76% |
| 2021-06-30 |
$4.10B |
$15.76B |
27.59% |
| 2021-03-31 |
$3.70B |
$15.03B |
26.14% |
| 2020-12-31 |
$2.45B |
$14.94B |
17.96% |
| 2020-09-30 |
$1.49B |
$13.74B |
11.24% |
| 2020-06-30 |
$0.78B |
$12.86B |
5.94% |
| 2020-03-31 |
$0.82B |
$12.90B |
6.17% |
| 2019-12-31 |
$1.33B |
$13.45B |
10.07% |
| 2019-09-30 |
$1.30B |
$13.43B |
9.94% |
| 2019-06-30 |
$1.31B |
$13.33B |
9.98% |
| 2019-03-31 |
$1.34B |
$12.66B |
10.28% |
| 2018-12-31 |
$1.33B |
$13.01B |
10.05% |
| 2018-09-30 |
$1.35B |
$13.29B |
10.20% |
| 2018-06-30 |
$1.33B |
$13.08B |
10.07% |
| 2018-03-31 |
$1.29B |
$13.34B |
10.08% |
| 2017-12-31 |
$1.31B |
$13.15B |
10.66% |
| 2017-09-30 |
$1.26B |
$13.33B |
10.77% |
| 2017-06-30 |
$1.25B |
$11.49B |
11.31% |
| 2017-03-31 |
$1.29B |
$11.05B |
11.69% |
| 2016-12-31 |
$1.27B |
$10.81B |
11.51% |
| 2016-09-30 |
$1.22B |
$11.00B |
11.04% |
| 2016-06-30 |
$1.21B |
$11.28B |
10.92% |
| 2016-03-31 |
$1.16B |
$11.14B |
10.62% |
| 2015-12-31 |
$1.00B |
$10.89B |
9.10% |
| 2015-09-30 |
$0.98B |
$10.92B |
10.16% |
| 2015-06-30 |
$0.91B |
$10.88B |
10.96% |
| 2015-03-31 |
$0.83B |
$11.12B |
11.95% |
| 2014-12-31 |
$0.90B |
$5.50B |
16.32% |
| 2014-09-30 |
$0.91B |
$5.69B |
16.44% |
| 2014-06-30 |
$0.91B |
$5.57B |
16.95% |
| 2014-03-31 |
$0.93B |
$5.40B |
17.79% |
| 2013-12-31 |
$0.99B |
$5.38B |
19.33% |
| 2013-09-30 |
$0.99B |
$5.12B |
19.80% |
| 2013-06-30 |
$0.99B |
$5.05B |
20.03% |
| 2013-03-31 |
$1.00B |
$4.95B |
20.64% |
| 2012-12-31 |
$1.02B |
$4.89B |
21.57% |
| 2012-09-30 |
$1.06B |
$4.89B |
22.62% |
| 2012-06-30 |
$1.05B |
$4.61B |
23.21% |
| 2012-03-31 |
$1.00B |
$4.58B |
22.41% |
| 2011-12-31 |
$0.95B |
$4.59B |
21.72% |
| 2011-09-30 |
$0.94B |
$4.31B |
21.88% |
| 2011-06-30 |
$0.94B |
$4.37B |
23.31% |
| 2011-03-31 |
$0.98B |
$4.21B |
26.44% |
| 2010-12-31 |
$0.98B |
$4.29B |
28.48% |
| 2010-09-30 |
$0.96B |
$3.19B |
30.50% |
| 2010-06-30 |
$0.96B |
$3.15B |
30.21% |
| 2010-03-31 |
$0.93B |
$3.12B |
29.04% |
| 2009-12-31 |
$0.94B |
$3.08B |
28.61% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$19.603B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
